Glutathione

FDA’s 2019 investigation found excess endotoxins in material used for sterile glutathione products after adverse events. Its August 2026 reminder describes additional recalls involving elevated endotoxin levels. Those reports concern actual product quality, not merely whether glutathione exists naturally in the body. ^{1, 2}

An antioxidant mechanism does not establish that an injected product improves a meaningful health outcome. A claim should identify the preparation, route, population and controlled evidence. Oral or topical findings cannot automatically validate an intravenous or injected formulation.

The ingredient source and pharmacy should be identified for any proposed preparation. A patient-specific 503A preparation is compounded by a state-licensed 503A pharmacy pursuant to a patient-specific prescription. Compounded drugs do not undergo FDA approval; this description is not a product endorsement or an availability claim. ³

Glutathione in food, oral supplements, inhaled preparations and injections are not interchangeable exposures. FDA's 2026 reminder warned compounders not to use dietary-supplement-grade glutathione for sterile products. That material may not meet expectations for injectable quality. A label that says pharmaceutical or high purity does not establish sterility, endotoxin control or suitability for intravenous use. Ask the pharmacy to identify the source grade, route, lot and quality controls for the exact preparation. ^{1, 2, 3}

FDA investigated adverse events after compounded glutathione injections associated with endotoxin contamination. Such reports establish that product-quality failures can cause real harm, including fever, chills, low blood pressure and hospitalization. They do not quantify the risk of every preparation, but they make sourcing and sterile-process questions essential. Fever, rigors, severe weakness, breathing difficulty, fainting or rapidly worsening illness after an injection or infusion requires urgent evaluation; do not interpret it as a cleansing reaction. ^{1, 2}

Glutathione is an important endogenous antioxidant, but that fact does not prove that a compounded injection detoxifies the body, lightens skin safely, prevents illness, treats a hangover or slows aging. Biomarker changes do not automatically translate into meaningful outcomes. A claim should specify the formulation, route, population, comparator, duration and measured endpoint. If a preparation combines glutathione with vitamins or other ingredients, benefits and adverse effects cannot be assigned to one component without direct evidence for the mixture. ^{1, 2, 3}

Inhaled glutathione can raise bronchospasm concerns in susceptible people, while oral absorption and exposure differ from injection. A benefit or harm from one route should not be automatically assigned to another. People with asthma, sulfite sensitivity or respiratory symptoms should discuss the exact product and route. New wheezing, throat tightness or breathing difficulty after any preparation warrants prompt assessment. ^{1, 2, 3}